ClinVar Miner

Submissions for variant NM_000059.4(BRCA2):c.8177A>T (p.Tyr2726Phe)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002427791 SCV002680451 uncertain significance Hereditary cancer-predisposing syndrome 2019-09-25 criteria provided, single submitter clinical testing The p.Y2726F variant (also known as c.8177A>T), located in coding exon 17 of the BRCA2 gene, results from an A to T substitution at nucleotide position 8177. The tyrosine at codon 2726 is replaced by phenylalanine, an amino acid with highly similar properties. This alteration was identified in a cohort of 912 epithelial ovarian cancer patients (Cunningham JM et al. Sci Rep, 2014 Feb;4:4026). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.